|Articles|October 3, 2012
Prostate-Cancer Test May Reduce Repeat Biopsies: Study
Advertisement
A new gene-based test for prostate cancer may reduce the need to repeat painful biopsies that can also cause serious infections, according to a study to be published in the Journal of Urology.
The ConfirmMDx test, sold by MDxHealth SA (MDXH) and based on technology developed at Johns Hopkins University, examined samples from biopsies and confirmed whether a patient was clear of cancer with 90 percent accuracy, according to the study of 498 men who underwent a second biopsy within 30 months. The findings will appear in the November issue of the journal, according to the Liege, Belgium-based company.
Read the full story:
Source: Bloomberg
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Three Years on Baricitinib Preserved Hair Regrowth in Severe Alopecia Areata
2
First Clinical Evidence of Gene Editing, Epigenetic Silencing of HBV cccDNA
3
Oz White House Briefing Touts Drug Savings and Fraud Cleanup, but Data Tell a Nuanced Story
4
5 Notable Oncology FDA Approvals Granted in May
5